French company Novacyte has released a diagnostic test for the Wuhan virus that generates a result in less than two hours, enabling more effective screening process

    0
    646
    • Novacyt stock soared 32% on Friday morning after the French cellular diagnostics company announced the launch of a new test for the coronavirus.
    • The test has been developed as a direct response to the recent outbreak of the new strain of coronavirus, which originated in the Chinese city of Wuhan and has now spread worldwide, leading the World Health Organization to declare a global health emergency.
    • The new test is able to detect only the 2019 strain of the virus, reducing the risk of a false diagnosis, the company said in a statement.
    • The test, generated by the company’s Primerdesign molecular diagnostics team, can also generate a result in less than two hours, enabling samples to be screened quickly, which the company says could help prevent the “Unnecessary” spread of the virus.
    • This week, more than 6,000 tourists were held on an Italian cruise ship after a woman broke out in a fever on board, but eventually tested negative for the coronavirus after samples were taken to a hospital in Rome.
    • In a statement Friday, Novacyt CEO Graham Mullis said the company believed this to be the first European test to be made available and had seen significant early demand from over 10 countries.
    • The test will be introduced this weekend at the Medlab Expo in Dubai.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.